Insider Transactions in Q1 2025 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 20
2025
|
Christopher S. Boerner Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+1.88%
|
$110,000
$55.05 P/Share
|
|
Feb 14
2025
|
Samit Hirawat EVP,Chief Med.Offr.,Drug Dev. |
BUY
Open market or private purchase
|
Direct |
1,823
+2.77%
|
$98,442
$54.84 P/Share
|
|
Feb 01
2025
|
Benjamin Hickey President, RayzeBio Org. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,725
-34.31%
|
$216,050
$58.95 P/Share
|
|
Feb 01
2025
|
Benjamin Hickey President, RayzeBio Org. |
BUY
Exercise of conversion of derivative security
|
Direct |
10,078
+48.14%
|
-
|
|
Feb 01
2025
|
Gregory Scott Meyers EVP, Chief Digital & Tech Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
833
-10.64%
|
$48,314
$58.95 P/Share
|
|
Feb 01
2025
|
Gregory Scott Meyers EVP, Chief Digital & Tech Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,543
+24.52%
|
-
|